Integrating metabolomics and molecular dynamics simulation to elucidate the anti-atherosclerotic mechanisms of Gynostemma pentaphyllum
Archives of Biochemistry and Biophysics · 2026-06 · 780 · 110793
DOI: 10.1016/j.abb.2026.110793 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2026-06. Verfasst von Wenyu Bu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Jiangsu Joint International Laboratory …. Hauptthemen laut MEDLINE: Gynostemma, Molecular Dynamics Simulation, Metabolomics, Atherosclerosis. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Jiangsu Provincial Health Commission, Jiangsu Commission of Health.
Abstract (Originalsprache)
BACKGROUND: Atherosclerosis (AS) is a leading global cause of cardiovascular mortality. Gynostemma pentaphyllum (GP), a well-recognized traditional Chinese medicine with a long history of medicinal application, has emerged as a promising candidate for anti-atherosclerotic intervention due to its well-documented potential in regulating cardiovascular homeostasis. PURPOSE: This study aimed to systematically elucidate the anti-atherosclerotic mechanisms of GP using metabolomics, network pharmacology, molecular docking, molecular dynamics (MD) simulations, and in vitro validation. METHODS: Leaf and root samples from five-leaf and seven-leaf gynostemma were analyzed by UHPLC-MS/MS for metabolite profiling. Active components and targets of GP were retrieved from TCMSP and PharmMapper, while AS-related targets were collected from GeneCards, OMIM, DrugBank, and DisGeNET. PPI networks were constructed using Cytoscape, and functional enrichment was analyzed via GO and KEGG. Molecular docking and MD simulations assessed binding affinities between GP components and core targets. Based on the bioinformatics analysis, PPARγ was chosen as a key therapeutic target for further in vitro experimental validation. RESULTS: Metabolomics identified 1898 compounds, with 208 differentially accumulated metabolites between GP varieties. Network pharmacology revealed 24 active components, 168 potential targets, and 69 AS-overlapping targets. Twelve core genes were identified, including AKT1, ALB, PPARγ, ESR1, CASP3, MMP9, EGFR, SRC, MMP2, MAPK1, MPO, and MAPK8. Enrichment analysis linked these targets to lipid metabolism, efferocytosis, and inflammation pathways. Molecular docking and MD simulations confirmed strong and stable binding of Gypenoside XL to PPARγ. Gypenoside A, one of the relatively abundant constituents among gypenosides (GPs), was also directly bound to PPARγ. In vitro, GPs reduced lipid accumulation, upregulated PPARγ and LXRα, suppressed NF-κB phosphorylation and nuclear translocation and attenuated oxidative stress. These coordinated regulations on lipid metabolism, inflammation, and oxidative stress collectively mitigate key pathological processes of AS, including foam cell formation and atherosclerotic plaque progression. CONCLUSION: GP exerts anti-atherosclerotic effects through a multi-component, multi-target mechanism, with activation of the PPARγ-LXRα pathway and inhibition of NF-κB driven inflammation being central to its therapeutic action.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Jiangsu Joint International Laboratory of Animal-Derived Chinese Medicine and Functional Peptides, Nanjing Un…
- School of Integrated Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210023, China.
- Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210028, China.
- Department of Cardiology, Yancheng TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Yancheng, Jiangsu, 224002, China.
Förderung
- National Natural Science Foundation of China
- Jiangsu Provincial Health Commission
- Jiangsu Commission of Health
- Excellent Young Scientists Fund
- Graduate Research and Innovation Projects of Jiangsu Province
Zitieren
APA
Bu, W., Xia, Y., Qiu, J., Zong, W., Zhu, S., Du, Y., Liu, Y., Yu, Q., Huang, X., Geng, Z., & Liu, F. (2026). Integrating metabolomics and molecular dynamics simulation to elucidate the anti-atherosclerotic mechanisms of Gynostemma pentaphyllum. Archives of Biochemistry and Biophysics, 780, 110793. https://doi.org/10.1016/j.abb.2026.110793
Vancouver
Bu W, Xia Y, Qiu J, Zong W, Zhu S, Du Y, et al. Integrating metabolomics and molecular dynamics simulation to elucidate the anti-atherosclerotic mechanisms of Gynostemma pentaphyllum. Archives of Biochemistry and Biophysics. 2026;780:110793. doi:10.1016/j.abb.2026.110793
BibTeX
@article{Bu2026,
author = {Bu, Wenyu and Xia, Yinghong and Qiu, Junwei and Zong, Wentian and Zhu, Shidian and Du, Yuying and Liu, Yanzi and Yu, Qiuyu and Huang, Xiaoling and Geng, Zhirong and Liu, Fuming},
title = {Integrating metabolomics and molecular dynamics simulation to elucidate the anti-atherosclerotic mechanisms of Gynostemma pentaphyllum},
journal = {Archives of Biochemistry and Biophysics},
year = {2026},
volume = {780},
pages = {110793},
doi = {10.1016/j.abb.2026.110793}
}
EUVIMED